21st Annual Meeting of the German Retina Society and 8th Symposium of the International Society of Ocular Trauma (ISOT)
German Retina Society
International Society of Ocular Trauma
19.06. - 22.06.2008, Würzburg
RG4: Anti-VEGF bei AMD
Meeting Abstract
(ISOTRG2008V110)
[Full Text]
1-year-results of Bevacizumab therapy for subfoveal choroidal neovascularisations in age related macular degeneration
Schrader WF, Walter L[Full Text]
Meeting Abstract
(ISOTRG2008V111)
[Full Text]
Efficicy and Safety of Intravitreal Bevacizumab (Avastin) on demand in neovascular Age-related Macular Degeneration. 12 Months Results.
Müller B, Porstmann AU[Full Text]
Meeting Abstract
(ISOTRG2008V113)
With Erratum (Jun 25, 2008)
[Full Text]
The use of anti-VEGF Inhibitors in wet AMD: balancing the risks
Blank RWith Erratum (Jun 25, 2008)
[Full Text]
Meeting Abstract
(ISOTRG2008V114)
[Full Text]
Inclusion and withdrawal criteria of intravitreal injections with ranibizumab (Lucentis®) in neovascular ARMD
Dave H, Wiegand W[Full Text]
Meeting Abstract
(ISOTRG2008V115)
[Full Text]
Ranibizumab for neovascular ARMD: Results of the Excite- and Sustatin-Studies
Eter NN, Meyer C, Clemens C, Holz FG[Full Text]
Meeting Abstract
(ISOTRG2008V116)
[Full Text]
Frühzeitige Behandlung mit Ranibizumab (Lucentis®) bei exsudativer AMD als notwendige Voraussetzung für Erfolg
Matthé E, Sandner D, Pillunat LE[Full Text]
Meeting Abstract
(ISOTRG2008V117)
[Full Text]
Combined Intravitreal Bevacizumab and Triamcinolone for Exudative Age-Related Macular Degeneration
Schlichtenbrede FC, Jonas JB, Libondi T, Golubkina L, Spandau UH, Rensch F[Full Text]
Meeting Abstract
(ISOTRG2008V118)
[Full Text]
Low-dose triamcinolone prolongs the effect of bevacizumab in patients with acute exsudative age related macular degeneration
Gerding H, Riese J, Loukopoulos V, Meier C, Timmermann M[Full Text]
Meeting Abstract
(ISOTRG2008V119)
[Full Text]
Ist die PDT noch aktuell?
Kaymak H, Mohammad G, Mester U[Full Text]
Meeting Abstract
(ISOTRG2008V120)
[Full Text]
Photodynamic Therapy with Verteporfin combined with Intravitreal Injection of Ranibizumab for Occult and Classic CNV in AMD
Maier M, Feucht N, Fiore B, Winkler C, von Mohrenfels C, Kook P, Fegert C, Lohmann CP[Full Text]
Meeting Abstract
(ISOTRG2008V121)
[Full Text]
Combination therapy for exudative ARMD: IECOMB study
Wolf S, Brinkmann CK, Berger L, Wolf-Schnurrbusch UEK[Full Text]
Meeting Abstract
(ISOTRG2008V122)
[Full Text]
Fundusautofluoreszenz nach intravitrealer VEGF-Hemmer Gabe
Hager A, Wiegand W[Full Text]
Meeting Abstract
(ISOTRG2008V123)
[Full Text]
Prognostische Faktoren bei der Anti-VEGF-Therapie der exsudativen AMD
Pauleikhoff D, Heimes B, Dietzel M, Zeimer M, Spital G, Lommatzsch A[Full Text]
Meeting Abstract
(ISOTRG2008V124)
[Full Text]
Gene therapy for retinal degeneration
Thumann G, Stöcker M, Walter P, Johnen S[Full Text]